1. Home
  2. Live Updates
  3. Michaela metzger

Live Breaking News & Updates on Michaela metzger

Stay informed with the latest breaking news from Michaela metzger on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Michaela metzger and stay connected to the pulse of your community

Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum

WALTHAM, Mass., April 10, 2024 /PRNewswire/ -- Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that...

Sharon-klahre , Michaela-metzger , Twitter , Virtual-targeted-oncology-forum-on , Linkedin , Syndax-pharmaceuticals-inc , Syndax-pharmaceuticals , Syndax-pharmaceuticals-nasdaq , Chief-executive-officer , Targeted-oncology-forum , Markets ,

Revumenib Earns FDA Priority Review in R/R KMT2Ar Acute Leukemia

Revumenib, a first-in-class Menin inhibitor, was granted priority review from the FDA for the treatment of adult and pediatric relapsed or refractory KMT2A-rearranged acute leukemia.

United-states , American , Michaela-metzger , American-society-of-hematology-annual-meeting , Syndax-pharmaceuticals , Hematology-annual ,

Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia

– Topline data expected in 4Q24 could support sNDA filing in 1H25 –

United-states , American , Neil-gallagher , Michaela-metzger , Sharon-klahre , Syndax-pharmaceuticals , Drug-administration , Prnewswire-syndax-pharmaceuticals-nasdaq , American-society-of-hematology-annual-meeting , Exchange-commission , Twitter , Linkedin

FDA Grants Priority Review to Revumenib for R/R KMT2A+ AML/ALL

The FDA granted priority review to the NDA seeking the approval of revumenib for the treatment of relapsed/refractory, KMT2A-rearranged acute leukemia.

Karnofsky-lansky , Michaela-metzger , Syndax-pharmaceuticals ,

Syndax Pharmaceuticals (SNDX) Granted FDA Priority Review of NDA for Revumenib

Syndax Pharmaceuticals (SNDX) Granted FDA Priority Review of NDA for Revumenib
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michaela-metzger , Drug-administration , Syndax-pharmaceuticals-nasdaq , Time-oncology-review-program , Syndax-pharmaceuticals , Priority-review , New-drug-application , Prescription-drug-user-fee-act , Chief-executive ,

Syndax Pharmaceuticals (SNDX) Reports Updates and Anticipated 2024 Milestones

Syndax Pharmaceuticals (SNDX) Reports Updates and Anticipated 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Michaela-metzger , Drug-administration , Syndax-pharmaceuticals-nasdaq , Md-anderson-cancer-center , American-society-of-hematology , Leukemia-lymphoma-society-beat , Company-updates , American-society-of-hematology-annual-meeting , Syndax-pharmaceuticals

Syndax Highlights Recent Updates and Anticipated 2024 Milestones

Syndax Highlights Recent Updates and Anticipated 2024 Milestones
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Sharon-klahre , Michaela-metzger , Leukemia-lymphoma-society-beat , Syndax-pharmaceuticals-inc , Md-anderson-cancer-center , European-commission , Drug-administration , American-society-of-hematology-annual-meeting , Linkedin , American-society-of-hematology

Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference

Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Sharon-klahre , Michaela-metzger , Linkedin , Syndax-pharmaceuticals-inc , Prnewswire-syndax-pharmaceuticals-nasdaq , Twitter , Syndax-pharmaceuticals , Chief-executive-officer , Healthcare-conference ,

Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference

Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan...

Michaela-metzger , Sharon-klahre , Prnewswire-syndax-pharmaceuticals-nasdaq , Syndax-pharmaceuticals , Syndax-pharmaceuticals-inc , Announces-presentation , Chief-executive-officer , Healthcare-conference ,

City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias

City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Phoenix , Arizona , Chicago , Illinois , Orange-county , Tatum-demontmorency , Letisia-marquez , Los-angeles , Michaela-metzger , Ibrahim-aldoss